This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
ND Adams , RW Gray & J Lemann Jr (1979) The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab 48, 1008–1016.
MH Ahonen , L Tenkanen , L Teppo , M Hakama & P Tuohimaa (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11, 847–852.
KC Balaji , RF Huryk , S Verhulst & WR Fair (2001) Growth of heterotopic LNCaP prostate cancer tumor in nude mice is not affected by dietary calcium. Prostate 48, 265–273.
JA Baron , M Beach , JS Mandel , (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340, 101–107.
JA Baron , M Beach , K Wallace , MV Grau , RS Sandler , JS Mandel , D Heber & ER Greenberg (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14, 586–589.
NH Bell (1998) Renal and nonrenal 25-hydroxyvitamin D-1α-hydroxylases and their clinical significance. J Bone Miner Res 13, 350–353.
NH Bell , PH Stern , E Pantzer , TK Sinha & HF DeLuca (1979) Evidence that increased circulating 1 α, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 64, 218–225.
SI Berndt , HB Carter , PK Landis , KL Tucker , LJ Hsieh , EJ Metter & EA Platz (2002) Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging. Urology 60, 1118–1123.
MM Braun , KJ Helzlsouer , BW Hollis & GW Comstock (1995) Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 6, 235–239.
J Caverzasio , C Montessuit & JP Bonjour (1990) Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25-dihydroxyvitamin D3. Endocrinology 127, 453–459.
JM Chan & EL Giovannucci (2001) Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 23, 87–92.
JM Chan , P Pietinen , M Virtanen , N Malila , J Tangrea , D Albanes & J Virtamo (2000) Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 11, 859–867.
D Feldman , P Malloy & C Gross (2001) Vitamin D: biology, action, and clinical implication. In Osteoporosis, pp. 257–303 [R Marcus , D Feldman and J Kelsey , editors]. San Diego, CA: Academic Press.
SL Ferrari , JP Bonjour & R Rizzoli (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90, 1519–1524.
JC Gallagher , BL Riggs , J Eisman , A Hamstra , SB Arnaud & HF DeLuca (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64, 729–736.
X Gao , MP LaValley & KL Tucker (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97, 1768–1777.
X Gao , ML Valley & KL Tucker (2006) Prospective studies of dairy and calcium intakes and prostate risk: a meta-analyisis. J Natl Cancer Inst 98, 795.
E Giovannucci (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16, 83–95.
E Giovannucci , Y Liu , MJ Stampfer & WC Willett (2006) A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 203–210.
WB Grant (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94, 1867–1875.
GH Guyatt , DL Sackett , JC Sinclair , R Hayward , DJ Cook & RJ Cook (1995) Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 274, 1800–1804.
MF Holick (2003) Vitamin D: a millenium perspective. J Cell Biochem 88, 296–307.
HJ Kalkwarf & BL Specker (2002) Bone mineral changes during pregnancy and lactation. Endocrine 17, 49–53.
E Kesse , S Bertrais , P Astorg , A Jaouen , N Arnault , P Galan & S Hercberg (2006) Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplementation en Vitamines et Mineraux Antioxydants) study. Br J Nutr 95, 539–545.
JF Ma , L Nonn , MJ Campbell , M Hewison , D Feldman & DM Peehl (2004) Mechanisms of decreased Vitamin D 1α-hydroxylase activity in prostate cancer cells. Mol Cell Endocrinol 221, 67–74.
WJ Maierhofer , RW Gray & J Lemann Jr (1984) Phosphate deprivation increases serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int 25, 571–575.
GJ Miller (1998) Vitamin D and prostate cancer: biologic interactions and clinical potentials. Cancer Metastasis Rev 17, 353–360.
AM Nomura , GN Stemmermann , J Lee , LN Kolonel , TC Chen , A Turner & MF Holick (1998) Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 9, 425–432.
DM Peehl & D Feldman (2003) The role of vitamin D and retinoids in controlling prostate cancer progression. Endocr Relat Cancer 10, 131–140.
EA Platz , MF Leitzmann , BW Hollis , WC Willett & E Giovannucci (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15, 255–265.
LQ Qin , PY Wang , T Kaneko , K Hoshi & A Sato (2004 a) Estrogen: one of the risk factors in milk for prostate cancer. Med Hypotheses 62, 133–142.
LQ Qin , JY Xu , PY Wang , T Kaneko , K Hoshi & A Sato (2004 b) Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies. Nutr Cancer 48, 22–27.
AG Renehan , M Zwahlen , C Minder , ST O'Dwyer , SM Shalet & M Egger (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363, 1346–1353.
AG Schuurman , PA van den Brandt , E Dorant & RA Goldbohm (1999) Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study. Br J Cancer 80, 1107–1113.
G Severi , DR English , JL Hopper & GG Giles (2006 a) Re: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 98, 794–795, .
G Severi , HA Morris , RJ MacInnis , DR English , WD Tilley , JL Hopper , P Boyle & GG Giles (2006 b) Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 1137–1141.
GA Sonn , W Aronson & MS Litwin (2005) Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis 8, 304–310.
A Tavani , P Bertuccio , C Bosetti , R Talamini , E Negri , S Franceschi , M Montella & C La Vecchia (2005) Dietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancer. Eur Urol 48, 27–33.
A Tavani , S Gallus , S Franceschi & C La Vecchia (2001) Calcium, dairy products, and the risk of prostate cancer. Prostate 48, 118–121.
TC Woo , R Choo , M Jamieson , S Chander & R Vieth (2005) Pilot study: potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr Cancer 51, 32–36.
MV Young , GG Schwartz , L Wang , DP Jamieson , LW Whitlatch , JN Flanagan , BL Lokeshwar , MF Holick & TC Chen (2004) The prostate 25-hydroxyvitamin D-1 α-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D. Carcinogenesis 25, 967–971.